Quantinno Capital Management
GMED icon

Quantinno Capital Management’s Globus Medical GMED Stock Holding History

Quantinno Capital Management’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$108M Buy
1,436,468
+217,370
+18% +$17.2M 0.1% 213
2026
Q2 		$96.3M Buy
1,219,098
+672,003
+123% +$57.1M 0.12% 174
2026
Q1 		$47.1M Buy
547,095
+321,824
+143% +$28.9M 0.08% 292
2025
Q4 		$19.7M Sell
225,271
-2,059
-0.9% -$156K 0.04% 524
2025
Q3 		$13M Buy
227,330
+213,880
+1,590% +$12.3M 0.04% 556
2025
Q2 		$794K Buy
13,450
+5,952
+79% +$385K ﹤0.01% 1396
2025
Q1 		$549K Buy
7,498
+2,825
+60% +$233K ﹤0.01% 1346
2024
Q4 		$387K Buy
4,673
+784
+20% +$61.8K ﹤0.01% 1306
2024
Q3 		$278K Buy
3,889
+606
+18% +$42.8K ﹤0.01% 1288
2024
Q2 		$225K Buy
+3,283
New +$196K ﹤0.01% 1239
2023
Q4 		– Sell
-53,055
Closed -$2.63M – 1086
2023
Q3 		$2.63M Buy
53,055
+16,767
+46% +$938K 0.12% 204
2023
Q2 		$2.16M Buy
36,288
+1,550
+4% +$88.3K 0.12% 206
2023
Q1 		$1.97M Buy
34,738
+10,835
+45% +$695K 0.13% 195
2022
Q4 		$1.78M Buy
+23,903
New +$1.63M 0.13% 214
2021
Q4 		– Sell
-3,315
Closed -$254K – 517
2021
Q3 		$254K Buy
+3,315
New +$266K 0.28% 179
2021
Q1 		– Sell
-10,378
Closed -$677K – 280
2020
Q4 		$677K Sell
10,378
-218
-2% -$12.5K 0.52% 7
2020
Q3 		$525K Buy
+10,596
New +$547K 0.35% 102
2020
Q2 		– Sell
-14,802
Closed -$630K – 365
2020
Q1 		$630K Buy
14,802
+7,599
+105% +$375K 0.39% 66
2019
Q4 		$424K Buy
7,203
+1,824
+34% +$99K 0.27% 145
2019
Q3 		$275K Buy
5,379
+391
+8% +$18.6K 0.19% 282
2019
Q2 		$211K Sell
4,988
-2,091
-30% -$90.8K 0.12% 384
2019
Q1 		$350K Buy
+7,079
New +$320K 0.22% 210

Other funds holding GMED

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $111B AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $26.8B AUM 3.69% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

Quantinno Capital Management's GMED Position: Q3 2026 in Review

Quantinno Capital Management increased its Globus Medical (GMED) stake by 18% in Q3 2026, buying an estimated $17.2M and bringing the position to 1,436,468 shares worth $108M. The position accounts for 0.1% of the portfolio, ranked #213.

Quantinno Capital Management first reported a position in GMED in Q1 2019 and has held it in 22 quarters since. 512 funds tracked by Wall St. Rank hold GMED as of Q3 2026.

  • Quantinno Capital Management held 1,436,468 shares of Globus Medical worth $108M as of Q3 2026.
  • Quantinno Capital Management bought 217,370 Globus Medical shares in Q3 2026, an estimated $17.2M.
  • Globus Medical made up 0.1% of Quantinno Capital Management's portfolio in Q3 2026, its #213 holding.
  • Quantinno Capital Management first reported a position in Globus Medical in Q1 2019 and has held it in 22 quarters since.
  • 512 funds tracked by Wall St. Rank held Globus Medical as of Q3 2026.

Based on Quantinno Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.